Mexico Intravenous Iron Drugs Market Size & Outlook

The intravenous iron drugs market in Mexico is expected to reach a projected revenue of US$ 42.0 million by 2030. A compound annual growth rate of 12.9% is expected of Mexico intravenous iron drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$18.0
Forecast, 2030 (US$M)
$42.0
CAGR, 2024 - 2030
12.9%
Report Coverage
Mexico

Mexico intravenous iron drugs market, 2018-2030 (US$M)

Mexico

Mexico intravenous iron drugs market highlights

  • The Mexico intravenous iron drugs market generated a revenue of USD 18.0 million in 2023 and is expected to reach USD 42.0 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 12.9% from 2024 to 2030.
  • In terms of segment, ferric carboxymaltose was the largest revenue generating product in 2023.
  • Ferric Carboxymaltose is the most lucrative product segment registering the fastest growth during the forecast period.


Intravenous iron drugs market data book summary

Market revenue in 2023USD 18.0 million
Market revenue in 2030USD 42.0 million
Growth rate12.9% (CAGR from 2023 to 2030)
Largest segmentFerric carboxymaltose
Fastest growing segmentFerric Carboxymaltose
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIron Dextran, Iron Sucrose, Ferric Carboxymaltose
Key market players worldwideAbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.6% of the global intravenous iron drugs market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil intravenous iron drugs market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 42.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intravenous Iron Drugs Market Companies

Name Profile # Employees HQ Website

Mexico intravenous iron drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.


Ferric carboxymaltose was the largest segment with a revenue share of 54.44% in 2023. Horizon Databook has segmented the Mexico intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.


According to NCBI data, CKD has become a serious health burden in Mexico. Due to an unfavorable healthcare reimbursement framework, the treated End-stage Renal Disease (ESRD) rate was 281 per million population for insured people and 130 per million population for uninsured people.

Hence, such factors are expected to drive the market in the country. Based on Halfway National Health and Nutrition Survey, the prevalence of anemia among Mexican children was 26.9% (aged 1-4 years), 12.5% (5-11 years), and 9.6% (12-19 years), which is further driving the regional market.

Reasons to subscribe to Mexico intravenous iron drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico intravenous iron drugs market databook

  • Our clientele includes a mix of intravenous iron drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico intravenous iron drugs market size, by product, 2018-2030 (US$M)

Mexico Intravenous Iron Drugs Market Outlook Share, 2023 & 2030 (US$M)

Mexico intravenous iron drugs market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more